🇯🇵 Invega Sustenna in Japan

PMDA authorised Invega Sustenna on 20 September 2013

Marketing authorisation

PMDA — authorised 20 September 2013

  • Marketing authorisation holder: JANSSEN PHARMACEUTICAL K.K.
  • Status: approved

Invega Sustenna in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Invega Sustenna approved in Japan?

Yes. PMDA authorised it on 20 September 2013.

Who is the marketing authorisation holder for Invega Sustenna in Japan?

JANSSEN PHARMACEUTICAL K.K. holds the Japanese marketing authorisation.